2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
Banach M, Surma S, Toth PP
Banach M, Surma S, Toth PP
Prof. Dan Gaita Prof. Zeljko Reiner Prof. Arrigo F.G. Cicero Prof. Daniel Pella Prof. Peter P. Toth Prof. Arman Postadzhiyan Prof. Zlatko Fras Prof. Agata Bielecka-Dąbrowa Prof. Peter E. Penson Prof. Ivan Pecin Prof. Piotr Jankowski